Blog
RSS FeedPosted by Michael Wonder on 10 Dec 2024
PHARMAC seeks feedback to fund medicines for liver and ovarian cancer
9 December 2024 - PHARMAC is consulting on a proposal to fund bevacizumab (branded as Vegzelma) as a cancer medicine ...
Posted by Michael Wonder on 05 Dec 2024
PHARMAC funds more cancer and respiratory medicines for New Zealanders
6 December 2024 - More publicly funded medicines are on the way for people with types of breast and lung ...
Posted by Michael Wonder on 03 Dec 2024
New Zealand Pharmaceutical Schedule - 1 December 2024
1 December 2024 - The December 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 12 Nov 2024
New heart medicine for 18,000 New Zealanders
12 November 2024 - PHARMAC has decided to fund the medicine empagliflozin for thousands of people with a type of ...
Posted by Michael Wonder on 11 Nov 2024
PHARMAC funds new medicine and removes renewal criteria for ADHD and narcolepsy treatments
11 November 2024 - PHARMAC will make two changes for people with attention deficit hyperactivity disorder (ADHD) and narcolepsy this ...
Posted by Michael Wonder on 08 Nov 2024
Newly funded medicine to benefit 110 more people with thyroid, liver, and kidney cancer
8 November 2024 - PHARMAC has decided to fund lenvatinib from 1 December 2024 for people with some types of ...
Posted by Michael Wonder on 07 Nov 2024
PHARMAC publishes agenda for the November 2024 PTAC meeting
6 November 2024 - PHARMAC has published the agenda for the upcoming 14-15 November 2024 PTAC meeting. ...
Posted by Michael Wonder on 01 Nov 2024
New Zealand Pharmaceutical Schedule - 1 November 2024
1 November 2024 - The November 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Nov 2024
10,000 New Zealanders set to benefit from PHARMAC budget increase
1 November 2024 - Thirteen new medicines funded from today will benefit thousands of New Zealanders with various health conditions ...
Posted by Michael Wonder on 31 Oct 2024
PHARMAC looks to fund a medicine to keep bones strong
31 October 2024 - PHARMAC is consulting on a proposal to widen access to denosumab for more people with osteoporosis and ...
Posted by Michael Wonder on 18 Oct 2024
PHARMAC seeking bids from suppliers for COVID-19 vaccines
17 October 2024 - PHARMAC is seeking bids from pharmaceutical suppliers of COVID-19 vaccines. ...
Posted by Michael Wonder on 10 Oct 2024
PHARMAC improves access to three cancer medicines
10 October 2024 - PHARMAC will improve access to three cancer medicines from 1 November 2024. ...
Posted by Michael Wonder on 08 Oct 2024
Updated information about PHARMAC's priority lists
8 October 2024 - PHARMAC’s quarterly Pūahoaho Report provides the latest information about applications for medicines, vaccines, and related products that ...
Posted by Michael Wonder on 01 Oct 2024
Rollout of new medicines across New Zealand begins
1 October 2024 - Today marks the first day a range of new medicines, including cancer medicines, will start to ...
Posted by Michael Wonder on 01 Oct 2024
New Zealand Pharmaceutical Schedule - 1 October 2024
1 October 2024 - The October 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...